Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
100%(4 trials)

Phase Distribution

Ph phase_4
3
60%
Ph phase_3
2
40%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
2(40.0%)
Phase 4Post-market surveillance
3(60.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(4)
Other(1)

Detailed Status

Completed4
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (40.0%)
Phase 43 (60.0%)

Trials by Status

completed480%
unknown120%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_4

Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP

NCT03722589
unknownphase_4

Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures

NCT04576377
completedphase_3

Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok

NCT00539981
completedphase_4

Comparison of Three Licensed Influenza Vaccines

NCT03068949
completedphase_3

Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age

NCT01825200

Clinical Trials (5)

Showing 5 of 5 trials
NCT03722589Phase 4

Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP

Completed
NCT04576377Phase 4

Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures

Unknown
NCT00539981Phase 3

Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok

Completed
NCT03068949Phase 4

Comparison of Three Licensed Influenza Vaccines

Completed
NCT01825200Phase 3

Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age

Completed

All 5 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
5